التفاصيل البيبلوغرافية
| العنوان: |
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study |
| المؤلفون: |
Monk, B.J. *, Brady, M.F., Aghajanian, C., Lankes, H.A., Rizack, T., Leach, J., Fowler, J.M., Higgins, R., Hanjani, P., Morgan, M., Edwards, R., Bradley, W., Kolevska, T., Foukas, P., Swisher, E.M., Anderson, K.S., Gottardo, R., Bryan, J.K., Newkirk, M., Manjarrez, K.L., Mannel, R.S., Hershberg, R.M., Coukos, G. |
| المصدر: |
In Annals of Oncology May 2017 28(5):996-1004 |
| قاعدة البيانات: |
ScienceDirect |
